Our Pipeline
Our pipeline consists of selected pharmaceutical and biotechnology assets at various stages of development
High-Value Assets
Assets with clear clinical and commercial potential
Focused on developing and advancing assets with strong clinical validation and clear commercial pathways. These solutions are designed to deliver measurable therapeutic impact while ensuring scalability, market readiness, and long-term value creation.
Regional Focus
Programs aligned with MENA market needs
Developing programs tailored to the specific healthcare priorities and demands of the MENA region. This approach ensures relevance, accessibility, and impactful outcomes by aligning innovation with local market needs and patient populations.
Value Growth
Opportunities for value creation through development progression
Advancing programs through strategic development stages to unlock increasing value at each milestone. This progression enhances clinical potential, strengthens market positioning, and creates scalable opportunities for long-term growth and return.